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Abstract 
 
Introduction: Lesions at ipsilateral systems related to postural control at 
ipsilesional side, may justify the lower performance of stroke subjects during 
walking. Purpose: To analyse bilateral ankle antagonist coactivation during 
double-support in stroke subjects. Methods: Sixteen (8 females; 8 males) 
subjects with a first isquemic stroke, and twenty two controls (12 females; 10 
males) participated in this study. The double support phase was assessed 
through ground reaction forces and electromyography of ankle muscles was 
assessed in both limbs. Results: Ipsilesional limb presented statistical 
significant differences from control when assuming specific roles during double 
support, being the tibialis anterior and soleus pair the one in which this atypical 
behavior was more pronounced. Conclusion: The ipsilesional limb presents a 
dysfunctional behavior when a higher postural control activity was demanded. 
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1. Introduction 
Walking performance can be substantially affected after stroke (Milot et 
al. 2006; Achache et al. 2010), decreasing the ability to return to work, 
participate in the community or perform other daily activities (Higginson et al. 
2006). 
Most of the literature emphasizes the contralesional deficits in the 
contralesional side in relation to hemispheric lesion (CONTRA). It is well known 
that the CONTRA paretic muscles contribute differently in gait sub-phases when 
compared to healthy subjects. It has been recently hypothesized that stroke 
subjects may have postural control impairment also in ipsilesional side (IPSI), 
based on the possibility of cortico-reticular system lesion in stroke involving the 
territory of middle cerebral artery (Silva et al. 2012a; Silva et al. 2012b). 
However, few studies analysed the ipsilesional limb performance (Peterson et 
al. 2010; Rosa et al. 2014). This recent hypothesis justifies the possibility of 
bilateral involvement in stroke subjects.  
During walking a consistent interlimb coordination has been 
demonstrated in subjects without neurological problems during step-to-step 
transition (double-support) (Sousa et al. 2012a; Sousa et al. 2012b). This 
functional connection between limbs (Hall et al. 2011; Anderson and Pandy 
2003; Sousa et al. 2012a; Sousa and Tavares 2012) is supported by studies 
that found strong crossed effects of group II fibers in motorneurons pools 
(Corna et al. 1996) and by the role of reticulospinal system (with IPSI disposal) 
(Schepens and Drew 2004). Changes in the function of reticulospinal system 
during walking can be analysed through postural control behavior of soleus 
muscle (SOL), when this muscle acts to provide body support. Actually, it has 
been demonstrated that subjects with middle artery territory stroke present 
dysfunctional behavior of this muscle in the IPSI when its action is related to 
body support (Silva et al. 2012b). In fact in a study developed by Sousa et. al., 
2013, a negative influence of IPSI SOL during loading response, as leading limb 
(LEAD), over forward propulsive, as trailing limb (TRAIL), muscles of CONTRA 
was found (Sousa et al. 2013).  
The dynamic relationship between limbs during walking, may also be 
analyzed through the levels of the antagonist coactivation ratio, related to 
functional position of each limb (TRAIL vs LEAD) and the subsequent role of 
each. In fact, during double support phase, TRAIL plantar flexors assume 
mainly the function of body support by SOL (McGowan 2008) and forward 
progression by GM action (Neptune et al. 2001; Anderson and Pandy 2003; Hall 
et al. 2011). LEAD limb is more related with smooth ground contact and weight 
acceptance, being the dorsi flexors the main agonists (Winter 1983). In this 
sense, it is important to evaluate the ankle antagonist coactivation when the 
LEAD limb is the IPSI and when the TRAIL is the CONTRA, but also when 
these roles are inverted. The present study aims to understand the behavior of 
each limb concerning the ankle antagonist coactivation between muscle pairs 
when assuming the role of TRAIL and LEAD. 
2. Methods 
Participants 
Sixteen (8 females; 8 males) subjects with a first isquemic subcortical 
stroke, and twenty two healthy subjects (12 females; 10 males) participated in 
this study.  
For the stroke subjects, the mean time since the injury was 26 months 
(SD=9). All subjects suffered an injury in the region of the middle cerebral 
artery, more specifically in the internal capsule, which was confirmed by brain 
computerized axial tomography. All subjects included had a score lower than 34 
on the Fugl–Meyer Assessment of Sensoriomotor Recovery After Stroke scale 
(Lamontagne et al. 2002a) and the capacity to perform gait without the use of 
orthoses. 
The stroke subjects have also preserved the cognitive function to 
understand orders, which was confirmed by assessment using the Mini-Mental 
State Examination. All potential subjects with previous history of neurologic 
pathology (e.g., Parkinson, pontine and cerebellar lesions), sensory impairment, 
diabetes, thrombophlebitis, history of lower limb surgery, and any orthopedic or 
rheumatoid conditions interfering with walking capacity were excluded, as well 
as subjects under medication that could affect the motor performance. 
Signals collected in the stroke group were compared with the obtained 
from sedentary healthy subjects, selected according to the same exclusion 
criteria applied to the stroke group. In addition, potential healthy subjects that 
had suffered any neurological disorder were excluded.  
All participants gave their informed consent according to the Declaration 
of Helsinki. 
Instruments 
Ground reaction forces were collected from two force plates (BERTEC 
Corporation, USA, FP4060-10 and FP4060-08 models) connected to a signal 
amplifier (from BERTEC, AM6300 model). The activity of the ankle agonist 
muscles of TRAIL (namely gastrocnemius medialis (GM), SOL (Neptune et al. 
2001)) and LEAD (namely tibialis anterior (TA) (Cappellini et al. 2006; Bonell et 
al. 2007)) were assessed through electromyography. The bilateral 
electromyographic signal of these muscles was monitored using a bioPLUX 
research wireless signal acquisition system (PLUX Wireless Biosignals S.A., 
Portugal). The signals were collected at a sampling frequency of 1000 Hz and 
were preamplified in each electrode  and then fed into a differential amplifier 
with an adjustable gain setting (25-500 Hz; common-mode rejection ratio: 110 
dB at 50 Hz, input impedance of 100 MΩ and gain of 1000). Self-adhesive silver 
chloride electromyographic electrodes (Dahlhausen®, Köln, Germany) were 
used in a bipolar configuration with a distance of 20 mm between detection 
surface centers. The skin impedance was measured with an Electrode 
Impedance Checker (Noraxon USA Inc). The electromyography and force 
platform signals were analyzed with the Acqknowledge software (Biopac 
Systems Inc). 
Procedures 
Preparation 
Immediately before the electrode placement, the skin was prepared to 
reduce the impedance to a level equal or inferior to 5 KΩ. 
Electrodes were placed in muscles midbelly according to anatomical 
references (Cheng et al. 2004; Klein et al. 2010). The ground electrodes were 
placed over each patella. 
Measurement 
After an explanation about the procedures, subjects were instructed to 
walk at their self-selected speed in a 8 meters walkway after a voice command. 
A self-selected walk speed was adopted since ankle plantar flexor muscles 
develop higher activity at this speed (Milot et al. 2008). To prevent fatigue, 1-
min rest between each trial was provided and the necessary repetitions were 
performed in order to obtain three valid trials. A trial was considered valid when 
at least one complete stance phase was collected by each force plate during 
the task. The electromyographic data were acquired from both lower limbs 
simultaneously. 
Data analysis 
The raw electromyographic signal and the ground reaction forces signal 
were processed using the Acqknowledge software. The raw electromyographic 
signal was filtered using a band-pass filter of 20 and 450 Hz, processed using a 
root mean square (RMS) procedure (Lamontagne et al. 2002a; Billot et al. 
2010), and normalized to mean signal over the entire gait cycle.  
The signals from the force plates were also filtered, using a low-pass 
filter of 8 Hz, and the force values were normalized to the weight of each 
subject (Turns et al. 2007). The double support phase was assessed through 
ground reaction forces. The beginning of double support during stance phase 
was defined as the interval where Fz of LEAD presents a value equal or higher 
than 7% of body weight, till the initiation of TRAIL swing phase (Sousa et al. 
2012a; Sousa et al. 2013). The EMG activity of each muscle was assessed 
during double support in two conditions: (a) when the IPSI limb was the TRAIL 
and the CONTRA was the LEAD, and (b) when the CONTRA was the TRAIL 
and the IPSI limb was the LEAD. The ankle antagonist coactivation was 
calculated according to the following formula: 
𝐴𝑛𝑡𝑎𝑔𝑜𝑛𝑖𝑠𝑡  𝑐𝑜𝑎𝑐𝑡𝑖𝑣𝑎𝑡𝑖𝑜𝑛  (%) = 𝑎𝑛𝑡𝑎𝑔𝑜𝑛𝑖𝑠𝑡  𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦𝑎𝑔𝑜𝑛𝑖𝑠𝑡 + 𝑎𝑛𝑡𝑎𝑔𝑜𝑛𝑖𝑠𝑡  𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦   ×100 
 
Statistics 
Using descriptive statistics, measures of central tendency (mean) and 
dispersion (standard deviation) for the magnitude of TA and SOL’s 
electromyographic activity were calculated. Taking into account the small 
sample size of both groups (n<10), it was assumed that the variables did not 
follow a normal distribution. Thus, the Wilcoxon Signed Rank Test was used to 
compare the magnitude of the muscles’ activity and antagonist coactivation 
between both lower limbs. The confidence interval used was equal to 95%, with 
a significance level of 0.05. 
3. Results 
Ankle antagonist coactivation in IPSI limb changes according to its role 
on walking, LEAD or TRAIL. In fact, non-significant differences were observed 
in relation to healthy control when IPSI limb assumes the role of LEAD (Table 
2). However, the antagonist coactivation between SOL and TA present 
statistical significant differences in relation to healthy control when in TRAIL 
position (Table 2). 
Contrary to what was expected, CONTRA limb presented values more 
similar to the healthy controls when assuming the TRAIL position (Table 2). 
4. Discussion 
The choice to study plantar flexor muscles (SOL and GM), instead of 
other proximal muscles, was based on the knowledge that, through sensorial 
feedback, they act as one functional unit (Cappellini et al. 2006) and are the 
main contributors to move the body forward (Grey et al. 2007; Lin et al. 2006; 
Neptune et al. 2008). However, while SOL contributes mostly to body support 
(McGowan 2008), GM acts mainly at providing forward progression (Neptune et 
al. 2001; Anderson and Pandy 2003; Hall et al. 2011). Based on the 
neurophysiologic mechanism of reciprocal enervation, TA was the antagonist 
selected to study coactivation process. It is also important to note that this study 
focus on the relation between pairs of muscles. Consequently, the results 
obtained could not reflect changes in individual muscle activity. In this sense, 
when both muscles present activation impairments, the antagonist coactivation 
in stroke subjects can be similar to the obtained in healthy subjects. However, 
this not mean that recruitment failure is not present, since this particular aspect 
was not evaluated. 
CONTRA limb antagonist coactivation 
Globally the results of the present study reveal that non-significant 
differences were observed between CONTRA limb and CONTROL, 
contradicting previous studies reviewed in (Rosa et al. 2014). However, these 
results doesn´t exclude possible muscle activation impairments in this limb 
(Olney and Richards 1996; Lamontagne et al. 2002b). Based on 
neurophysiology, it would be expected that when assuming LEAD position, the 
CONTRA limb would present ankle antagonist coactivation dysfunction as a 
result of a higher impairment in TA recruitment (agonist role) subsequent from 
the corticospinal lesion. However, the possible dysfunction of postural control 
system, also described in stroke subjects in this limb, can lead to a decreased 
activity of the antagonist activity (SOL and GM) (Sousa et al. 2013). This can 
explain the lack of differences observed in ankle coactivation comparing to 
CONTROL, when assuming the LEAD position. The same reasoning may 
explain findings obtained in CONTRA while assuming the LEAD position. In 
fact, both TA and GM are predominantly phasic muscles, and so both may 
express an atypical behavior in subcortical stroke in middle cerebral artery 
territory by the dependence of these muscles on the dorsolateral system. The 
SOL as a tonic muscle (Anderson and Pandy 2003; Hall et al. 2011; Neptune et 
al. 2001), depends of ventro- medial systems enervation. The possible lesion of 
both systems in this kind of stroke subjects GM, can justify the lack of 
differences in coactivation between these muscles comparing to CONTROL. 
IPSI limb antagonist coactivation 
Despite the postural control demand associated to initial contact and 
loading response, non-significant differences were observed between IPSI limb 
and CONTROL. These results can be explained by the fact that TA have a 
major role in stability during this phase (Chow et al. 2012) whose activity is 
dependent mostly from unimpaired dorsolateral system control. When this limb 
was the TRAIL, this behavior was no longer similar to those evidenced by the 
CONTROL, being the TA/SOL the pair in which this atypical behavior was more 
pronounced. This result can be explained by the knowledge of ipsilateral 
disposal ventromedial system that as a strong influence over predominantly 
postural muscles like SOL (Figure 1). Taking this into consideration, the results 
of the present study seems to indicate that the IPSI limb postural control 
dysfunction, associated to a possible lesion of ventromedial systems, interferes 
with the body support function during forward propulsion. This hypothesis hasn´t 
been questioned in previous studies about antagonist coactivation in stroke 
subjects as the changes observed in IPSI limb have been interpreted has a 
compensatory adaptative strategy (Lamontagne et al. 2000; Chow et al. 2012; 
Rosa et al. 2014). It is important to note that, since our study is dedicated to 
antagonist coactivation and not to individual muscle activity, future studies are 
required to confirm this possibility. In other hand, it should be highlighted that 
our criteria to selecting participants for our study based on vascular territory and 
lesion area hasn´t been frequently considered in previous studies. Based on 
this, the differences obtained in the present study in relation to previous studies 
(Chow et al. 2012; Lamontagne et al. 2000) as to ankle coactivation can be 
related to this aspect. 
Our findings present a novel insight into post-stroke neuro–motor 
impairment, since also points out difficulties in IPSI limb possibly related to the 
vascular lesion. 
5. Conclusions 
The ipsilesional limb presents a dysfunctional behavior when a higher 
postural control activity was demanded (as when assumed the trailing position). 
This dysfunction was more pronounced in soleus and tibialis anterior muscle 
pair as a result of a possible higher relation of soleus muscle with postural 
control demand. 
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FIGURE CAPTIONS 
 
Figure 1. Representation of the influence of the ventromedial disposed 
system on ipsilesional (IPSI) limb action when assuming the TRAIL position 
during the double-support (DS) phase of walking, in subjects with subcortical 
stroke in the territory of the middle cerebral artery. 
  
TABLE CAPTIONS 
 
Table I. Mean and standard deviation (SD) values of age, height, and 
weight of the healthy and stroke groups. The values of the self-selected walking 
speed adopted by each group are also indicated. 
 
Table II. Antagonist coactivation ratio of TRAIL and LEAD limb of 
stroke and healthy subjects. 
 
  
FIGURES 
 
 
Figure 1 
Control group Stroke group
Variables Mean ± SD Mean ± SD p Value
Age (years) 49.24 ± 7.69 53.87 ± 7.17 0.070
Height (m) 1.66 ± 0.09 1.65 ± 0.10 0.942
Body weight (kg) 67.40 ± 8.76 75.29 ± 7.03 0.006
Self-selected gait speed
(m/s)
1.00 ± 0.03 0.57 ± 0.13 <0.001
TABLE I
Stroke group Healthy group
Limb action Muscle pairs Limb Mean p Value Mean p Value
LEAD SOL/TA CONTRA 51.2 0.09 58.5 0.452
IPSI 61.3 0.713 GM/TA CONTRA 52.4 0.04
62.9 0.163 IPSI 63.3 0.946
TRAIL SOL/TA CONTRA 35.1 0.02 39.7
0.359 IPSI 54.2 0.005
GM/TA CONTRA 31.4 0.02 36.1 0.309
IPSI 47.5 0.062
Bold values are statistically significant p values.
TABLE II
